Episode 266: 265. Semaglutide and Cardiovascular Events in Non-Diabetics (secondary prevention) SELECT TRIAL
The primary cardiovascular end point was a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke in a time-to-first-event analysis.Improvement innonfatal st...
9 Apr 20248min
Episode 265: 264. Does a Lidocaine Patch Work for Neck Pain?
Bottom line(ZTLido 1.8%) is a brand name lidocaine patch currently approced for postherpetic neuralgia and will stay that why for now as it did not beat placebo for the treatment of patients with chro...
5 Apr 20245min
Episode 264: 263. Rates of Atrial Fibrillation 12 months After Onset of Hospitalized Transient AF
patients who have new-onset transient AF detected during a hospitalization for noncardiac surgery or medical illness and are discharged in sinus rhythm, approximately 1 in 3 have AF detected in the ye...
4 Apr 20247min
Episode 263: 262. Does Omalizumab Help For Peanut Allergy?
Bottom line Omalizumab does seem to improve allergic reactions to peanuts but comes at a steep price tag. Likely only allergist will prescribe this drug but it is worth know about If you know or take ...
3 Apr 20248min
Episode 262: 261. Are Combined Oral Contraceptives Effective for Treating Acne?
At ~24 weeks, ~80-90% of females report improvement in their acne with COCs, compared to 50-80% placebo, and 30-50% will have clear-almost clear skin versus 10-40% on placebo. Efficacy appears similar...
2 Apr 20249min
Episode 260: QM on Spring Break
QM on Spring Break-- but do you like the new format? Andrewbuelt@gmail.com
20 Mars 202452s
Episode 261: 260. SGLT2 Summary Recap
Diabetic patient- Empagliflozin prevents death from cardiovascular causes: NNT 46 per 3.1 yrs ($600 a month, 1 million dollars per life saved)-HFpEF- SGLT2 inhibitors do not prevent death and cost rou...
19 Mars 20246min
Episode 259: 259. EMPULSE Trial- Empagliflozin and Win Ratios
These findings indicate that initiation of empagliflozin in patients hospitalized for acute heart failure is well tolerated and results in significant clinical benefit in the 90 days after starting tr...
18 Mars 20249min
